Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taimur Sher

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Leukemia & Lymphoma|July 21, 2012
Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1Kasyapa S Chitta, Aneel Paulus, Sikander Ailawadhi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Cardiac Troponin T Elevation Predicts Mortality in Hospitalized COVID-19 PatientsKatelyn A Bruno, R Scott Wright, Joshua Culberson, et al.
Blood Cancer Journal|September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinibPaul J Hampel, Kari G Rabe, Timothy G Call, et al.
Blood Advances|October 15, 2025
AL Amyloidosis: A Real-World Experience with CAR-T Cell TherapyMelinda Sy Tan, Rahma Warsame, Ricardo D Parrondo, et al.
American Journal of Hematology|October 13, 2022
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosisMatthew Ho, Saurabh Zanwar, Francis K Buadi, et al.
Blood|September 12, 2022
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significanceMatthew Ho, Saurabh Zanwar, Francis K Buadi, et al.
Blood Cancer Journal|November 24, 2022
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathySaurabh Zanwar, Matthew Ho, Francis K Buadi, et al.
Mayo Clinic Proceedings|March 15, 2017
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted TherapyDavid Dingli, Sikander Ailawadhi, P Leif Bergsagel, et al.
Clinical Transplantation|January 8, 2025
Amyloidosis and Heart Transplantation in a New EraMelissa A Lyle, Juan Maria M Farina, Erin Wiedmeier-Nutor, et al.
Mayo Clinic Proceedings|April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|July 21, 2012
Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1Kasyapa S Chitta, Aneel Paulus, Sikander Ailawadhi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Cardiac Troponin T Elevation Predicts Mortality in Hospitalized COVID-19 PatientsKatelyn A Bruno, R Scott Wright, Joshua Culberson, et al.
Blood Cancer Journal|September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinibPaul J Hampel, Kari G Rabe, Timothy G Call, et al.
Blood Advances|October 15, 2025
AL Amyloidosis: A Real-World Experience with CAR-T Cell TherapyMelinda Sy Tan, Rahma Warsame, Ricardo D Parrondo, et al.
American Journal of Hematology|October 13, 2022
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosisMatthew Ho, Saurabh Zanwar, Francis K Buadi, et al.
Blood|September 12, 2022
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significanceMatthew Ho, Saurabh Zanwar, Francis K Buadi, et al.
Blood Cancer Journal|November 24, 2022
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathySaurabh Zanwar, Matthew Ho, Francis K Buadi, et al.
Mayo Clinic Proceedings|March 15, 2017
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted TherapyDavid Dingli, Sikander Ailawadhi, P Leif Bergsagel, et al.
Clinical Transplantation|January 8, 2025
Amyloidosis and Heart Transplantation in a New EraMelissa A Lyle, Juan Maria M Farina, Erin Wiedmeier-Nutor, et al.
Mayo Clinic Proceedings|April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Pageof 12